Inga B Leske

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Smoking Cessation

Tyrosine Kinase

Capillary Electrophoresis

Crystal Structure

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 38 (9) (2024)
Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 38 (9) (2024)
Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia (2024)
Inga B Leske, Oliver Hantschel
The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib. Leukemia 38 (9) (2024)
Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis, Inga B Leske, Delphine Rea, Stacey Phan, Kaeli B Miller, Feifei Hu, Anjeli Mase, Yibing Shan, Oliver Hantschel, Matthew P Jacobson, Neil P Shah
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Blood 144 (6) (2024)